Mahamaya Lifesciences IPO
GMP, Subscription, Price, Dates & Financial Details
Trading
Mahamaya Lifesciences LimitedIncorporated: 2002 Industry: Agrochemicals and Bioproducts Core Activities: Manufacturing, registration, and export of crop protection and soil health management productsCompany OverviewMahamaya Lifesciences Limited is a leading agrochemical company established in 2002,…
Open Date
Tue, 11 Nov 2025
Close Date
Thu, 13 Nov 2025
Price Band
₹ 108 – 114
Lot Size
1200
Issue Size
₹ 70.44 Cr
Minimum Investment
₹ 273,600 (2400 Shares)
Grey Market Premium Analysis
Day Wise GMP→Unofficial premium quoted in the grey market, tracked daily against the price band cap.
Grey market trading is unregulated. GMP figures are indicative only and should not be the sole basis for investment decisions - treat as a sentiment indicator, not a guarantee.
IPO Details
Mahamaya Lifesciences IPO has successfully completed its IPO process and is now listed on BSE SME Platform. According to the Red Herring Prospectus (RHP), the IPO was a book-built issue with a total issue size of ₹70.44 Crore, comprising a fresh issue of 53.29 Lakh equity shares aggregating to ₹60.75 Crore and an offer for sale (OFS) of 5.40 Lakh equity shares aggregating to ₹6.16 Crore by the existing shareholders.
The Mahamaya Lifesciences IPO remained open for subscription from November 11, 2025, to November 13, 2025. The basis of allotment was finalized on November 14, 2025, and the company's shares were listed on BSE SME Platform on November 18, 2025.
The company had fixed the price band at ₹108 to ₹114 per share, with a lot size of 1200 shares. Retail investors were required to make a minimum investment of ₹273,600 (based on the upper price band) to apply for one lot.
KFin Technologies Limited served as the registrar to the issue. Oneview Corporate Advisors Private Limited acted as the Book Running Lead Managers (BRLMs) to the issue.
With the successful completion of the IPO process, Mahamaya Lifesciences Limited is now a publicly listed company on BSE SME Platform. Investors can track the company's share price, trading performance, financial results, and corporate announcements through the stock exchanges.
Mahamaya Lifesciences IPO Timeline (Tentative)
- IPO Open Date
- Tue, 11 Nov 25
- IPO Close Date
- Thu, 13 Nov 25
- Basis of Allotment
- Fri, 14 Nov 25
- Initiation of Refunds
- Mon, 17 Nov 25
- Credit of Shares to Demat
- Mon, 17 Nov 25
- Listing Date
- Tue, 18 Nov 25 — NSE & BSE
Open Date
11 November 2025
Close Date
13 November 2025
Basis Of Allotment
14 November 2025
Listing Date
18 November 2025
IPO Subscription
Check Live Subscription →The Mahamaya Lifesciences IPO has received bids for 70,23,600 shares against 41,17,200 shares offered, resulting in an overall subscription of 1.71x. the NII category is subscribed 3.99x, Retail Investors 1.02x, and QIBs 1.19x.
QIB
1.19x
NII
3.99x
RII
1.02x
Total
1.71x
IPO Reservations
The Retail Individual Investor (RII) category has the highest allocation with 20,59,200 shares, representing 50.01% of the total issue. Qualified Institutional Buyers (QIBs) are allocated 11,76,000 shares (28.56%), while Non-Institutional Investors (NIIs) receive 8,82,000 shares (21.42%).
| Category | Shares Offered | Shares Offered % |
|---|---|---|
| Qualified Institutions | 1,176,000 | 28.56% |
| Non-Institutional | 882,000 | 21.42% |
| BNII | 588,000 | 14.28% |
| SNII | 294,000 | 7.14% |
| Retail Investors | 2,059,200 | 50.01% |
| Total | 4,117,200 | 100% |
Financials Details(₹ in Crores)
| Particular | 30 Jun 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 218.87 | 188.35 | 112.07 | 77.88 |
| Revenue | 84.04 | 267.17 | 162.83 | 137.4 |
| Profit After Tax | 4.1 | 12.94 | 5.22 | 3.75 |
| Net Worth | 53.5 | 49.42 | 24.66 | 19.44 |
| Reserve & Surplus | 35.73 | 31.66 | 23.41 | 18.19 |
| Total Borrowings | 57.72 | 58.11 | 54.63 | 24.37 |
Financials Performance
Performance Indicators
EPS Pre
Earnings per share before the IPO.
P/E Pre
IPO Offer Price ÷ EPS Pre.
EPS Post
Expected earnings per share after the IPO..
P/E (Post Issue)
IPO Offer Price ÷ EPS Post.
Mahamaya Lifesciences Limited KPI Information
| Particular | KPI as of Mon | Mar 2024 | Mar 2023 |
|---|---|---|---|
| ROE % | 34.94 | 23.67 | 21.34 |
| ROCE % | 23.15 | 16.16 | 20 |
| RoNW % | 26.19 | 21.16 | 19.29 |
| Pat Margin % | 4.84 | 3.2 | 2.73 |
Peers Comparison
| Company | Face Value | PE Ratio | EPS Basic | EPS Diluted | RoNW | Net Assets |
|---|---|---|---|---|---|---|
| Mahamaya Lifesciences Ltd | 10 | 0.00 | 7.60 | 7.60 | 26.19 | 27.82 |
| Nova Agritech Ltd | 2 | 16.93 | 3.05 | 3.05 | 12.47 | 23.76 |
| Bhagiradha Chemicals & Industries Litd | 1 | 247.63 | 1.14 | 1.14 | 2.03 | 52.61 |
About Mahamaya Lifesciences Limited
Mahamaya Lifesciences Limited
Incorporated: 2002
Industry: Agrochemicals and Bioproducts
Core Activities: Manufacturing, registration, and export of crop protection and soil health management products
Company Overview
Mahamaya Lifesciences Limited is a leading agrochemical company established in 2002, engaged in the manufacturing, registration, and export of high-quality crop protection products and bioproducts. The company is dedicated to enhancing crop and soil health and supporting the farming community in improving agricultural productivity and sustainability.
The company specializes in the formulation of pesticides and the supply of bulk agrochemical products to domestic agrochemical companies as well as multinational corporations (MNCs).
Mahamaya Lifesciences imports scientifically researched molecules, registers them with the Central Insecticides Board (CIB), and markets them as technical-grade and value-added formulations. These products cater to both domestic manufacturers and global MNCs.
With a strong focus on international expansion, the company has invested in global product registrations, actively operating in markets such as the Dominican Republic, Egypt, Ethiopia, Jordan, the UAE, and Turkey. The company provides high-quality products along with comprehensive data support for regulatory registrations in these countries.
Product Portfolio
1. Bulk Formulation Sales
- Acetamiprid SP
- Buprofezin SC
- Emamectin Benzoate SG
- Imidacloprid SC
- Paraquat Dichloride SC
2. Technical Sales
- Acetamiprid Technical (99% Min)
- Atrazine Technical (95% Min)
- Imidacloprid Technical (95% Min)
- Emamectin Benzoate Technical (95% Min)
3. Branded Product Sales
Major in-house branded formulations include:
- MAYAMRIT GR
- MAYAMRIT SL
- MAYAGIBB
- UCHIT EW 370
4. Export Formulations
Key exported formulations marketed under proprietary brands:
- Wiper – Sulphur 80% WDG
- Lancha – Pendimethalin 50% EC
- Tolfen – Tolfenpyrad 15% EC
- Typic – Sulphur 80% WG
Global Presence
Mahamaya Lifesciences continues to strengthen its international footprint through product registrations and partnerships across Asia, the Middle East, and Africa, ensuring sustainable and reliable crop protection solutions for global agriculture.
Mahamaya Lifesciences IPO Promoters
- Mr. Krishnamurthy Ganesan
- Mr. Prashant Krishnamurthy
- Mrs. Lalitha Krishnamurthy
Promoters Holding
Holding Pre Issue
77.27%
Holding Post Issue
56.35%
Mahamaya Lifesciences IPO Objective
The Company Mahamaya Lifesciences IPO proposes to utilise the Net Proceeds from the Issue towards the following objects.
- Purchase of Equipment for existing Formulation plant
- Funding capital expenditure towards setting up of a new Technical manufacturing plant
- Construction of Warehouse Building and Purchase of Machinery
- Funding working capital requirement of our Company
- General Corporate purposes
Mahamaya Lifesciences Limited Address / Contact Details
Mahamaya Lifesciences Ltd.
Unit No: DPT – 033, Ground Floor,
Plot No: 79 – 80, DLF Prime Tower,
Block, Okhla, Phase – 1
Delhi, New Delhi, 110020
Phone: +91-1146561474
Email: cs@mahamayalifesciences.com
Website: https://www.mahamayalifesciences.com/
IPO Snapshot
Mahamaya Lifesciences IPO Lot Size
The Mahamaya Lifesciences IPO has a lot size of 1,200 shares. Retail investors require a minimum investment of ₹2,73,600 by applying for 2 lot (2,400 shares). The maximum application allowed for the retail category is 2 lots (2,400 shares), requiring an investment of ₹2,73,600.
| Application | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 2 | 2,400 | 273,600.00 |
| Retail (Max) | 2 | 2,400 | 273,600.00 |
| S-HNI (Min) | 3 | 3,600 | 410,400.00 |
| S-HNI (Max) | 7 | 8,400 | 957,600.00 |
| B-HNI (Min) | 8 | 9,600 | 1,094,400.00 |
Issue Reservation
- QIB — 28.56%
- NII — 21.42%
- RII — 50.01%
Book Running Lead Managers
- Oneview Corporate Advisors Private Limited
IPO Documents & Links
Explore More IPOs
Currently Open
Coming Up Next
Disclaimer: This data is for informational purposes only and does not constitute investment advice.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
What is the Mahamaya Lifesciences IPO?
Mahamaya Lifesciences IPO is a Book-building IPO with a total issue size of ₹70.44 crore. The Mahamaya Lifesciences IPO price band is ₹108 to 114 per share. The Mahamaya Lifesciences IPO subscription opens on Tue, Nov 11, 2025, and closes on Thu, Nov 13, 2025. The Mahamaya Lifesciences IPO will be listed on the BSE. KFin Technologies Limited is the registrar for the Mahamaya Lifesciences IPO.
When will the Mahamaya Lifesciences IPO open for subscription?
The Mahamaya Lifesciences IPO opens on Tue, Nov 11, 2025 and closes on Thu, Nov 13, 2025
What is Mahamaya Lifesciences IPO Price Band?
Mahamaya Lifesciences IPO Price Band is ₹108 to 114 per share.
What is Mahamaya Lifesciences IPO Lot Size?
Mahamaya Lifesciences IPO lot size is 1200 shares, Retail investors need a minimum investment of ₹273600 based on the upper price band
What is the minimum investment for Mahamaya Lifesciences IPO?
The minimum investment for Mahamaya Lifesciences IPO is ₹273600, based on one lot of 1200 shares at the upper price band of ₹114 per share.
How to apply for Mahamaya Lifesciences IPO?
Investors can apply for the Mahamaya Lifesciences IPO through the ASBA (Application Supported by Blocked Amount) facility offered by their bank or through UPI using a SEBI-registered broker or trading app. Select the desired lot size, enter your bid within the price band, and submit the application before Thu, Nov 13, 2025. The application amount remains blocked until the Mahamaya Lifesciences IPO allotment is finalized.
What is Mahamaya Lifesciences IPO Issue Size?
Mahamaya Lifesciences IPO issue size is ₹70.44 crores.
What is the Mahamaya Lifesciences IPO Allotment Date?
Mahamaya Lifesciences IPO allotment date is Fri, Nov 14, 2025.
Who is the Mahamaya Lifesciences IPO Registrar?
The registrar for Mahamaya Lifesciences IPO is KFin Technologies Limited. Investors can go to KFin Technologies Limited website to check Mahamaya Lifesciences IPO allotment status, refund processing, and other IPO-related information.
Who is the Mahamaya Lifesciences IPO Lead Manager?
The book-running lead managers (BRLMs) for the Mahamaya Lifesciences IPO are Oneview Corporate Advisors Private Limited. The lead managers are responsible for managing the IPO process, including issue structuring, regulatory compliance, marketing the public issue, coordinating with investors, and ensuring a smooth listing process. For complete details, investors should refer to the Mahamaya Lifesciences IPO Red Herring Prospectus (RHP).